Reach Us +1-217-403-9671
Developing Regulatory Environment In South Asia And Challenges For Regulatory Affairs Professionals | 7504
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Developing regulatory environment in South Asia and challenges for regulatory affairs professionals

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Nadeem H. Alamgir

Accepted Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.008

South Asia, is the southern region of the Asian continent, which comprises the sub-Himalayan countries including Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka. It is home to well over one fifth of the world's population, thus is the most densely populated geographical region in the world. This Region includes the countries that were part of the former British Empire including India, Pakistan, and Bangladesh at the core, but also including Sri Lanka, Burma. The Drug Regulations developed by the British during their rule in this region are still the bases of Drug Regulation in these countries. The common issues are a colonial mindset of bureaucracy, lack of resources for capacity building of regulatory authorities/MOH. But the prevailing law gives immense powers to the bureaucrats in these authorities. With new emerging regulations for Pharmaceutical, Medical Devices and Biological Drugs in the developed world, a need for having the same set of regulations is felt by the regulators as well. But the resource constraints and lack of training in emerging of relevant regulations is either nonexistent or painstakingly slow and the authorities are trying to manage in unique ways. Thus becoming a challenge for Regulatory Affairs Professionals as the authorities are coming up with novel ideas nonexistent elsewhere.. To tap the immense potential of this huge market the issues in regulation of the drugs shall be addressed for the benefit of all.
Nadeem Alamgir started his carrier as a Sales Representative in MSD in 1985. He grew over the years in sales in different Pharmaceutical firms and then switched to Regulatory Affairs. While working as regulatory affairs professional he worked with the Government of Pakistan for Pharmaceutical Sector Reforms and amendment of The Drugs Act 1976 of Pakistan, formulation of regulations for Biological Drugs and Medical Devices Regulation. He was instrumental for membership of Pakistan Asian Harmonization Working Party (AHWP) and was able to motivate the authorities to create a separate Medical Device and Biological Drugs department in Drugs Regulatory Agency of Pakistan. He is also the Non Regulatory Primary Member of (AHWP) Asian Harmonization Working Party.